Since a positive ANA test result is an important component in the triage and diagnosis of patients with possible SARD, ANA-HEp-2 testing outside a proper clinical framework may yield a sizable portion of ANA-positive apparently HI, causing concern and anxiety in patients and physicians [13], and may lead to prescribing inappropriate and potentially toxic therapeutics [18]. The gene discussed is BTG3; the disease is Anxiety.